Treatment of ankylosing spondylitis with TNF inhibitors does not have adverse effect on results of liver function tests: a longitudinal study


ÇAPKIN E., KARKUCAK M., COŞAR A. M. , AK E., KARACA A., Gokmen F., ...More

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, vol.18, no.5, pp.548-552, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 18 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.1111/1756-185x.12311
  • Journal Name: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.548-552
  • Keywords: alanine transaminase, ankylosing spondylitis, aspartate transaminase, disease activity, TNF inhibitors, AUTOIMMUNE HEPATITIS, RHEUMATOID-ARTHRITIS, NO RELAPSE, INFLIXIMAB, PATIENT, ETANERCEPT, TOXICITY, DISEASES

Abstract

AimTo retrospectively investigate and compare the effects of tumor necrosis factor alpha inhibitors (TNFi) on hepatic enzymes in ankylosing spondylitis (AS) patients.